Table 2.
ADHD–TDC | ||||||
---|---|---|---|---|---|---|
Stim. | Regions | Measure | Comp./Freq. | Time (ms) | Electrodes | Sig. 1 |
Cue | Posterior Figure 3 |
ERP | ↓P1-N2 | 115–205 | Oz, O1, O2 | p < 0.009 |
↑N2 | 170–191 | Pz, P3 | p < 0.045 | |||
ERSP | ↓β (27–32) | 238–485 | Oz, O1, O2, P4 | p < 0.044 | ||
↓γ (40–43) | 332–427 | Oz, O2, O1 | p < 0.049 | |||
ITC | ↓θ (4–8) | 261–425 | Oz, O1, O2, Pz, P3, P4 | p < 0.039 | ||
↑β (25–30) | 273–422 | Oz, O1, P4, P3 | p < 0.044 | |||
Anterior | ERP | ↓N1 | 121–161 | Fz, F3, F4, Fpz | p < 0.018 | |
↑P2 | 223–273 | Fz, F3, F4, Fpz | p < 0.019 | |||
ERSP | ↓α (9–12) | 150–312 | Fz, F3, F4 | p < 0.035 | ||
ITC | ↓α (10–13) | 101–263 | Fz, F4 | p < 0.049 | ||
Go | Posterior | ERP | ↓P1-N2 | 146–189 | Oz, O1, O2, Pz, P3 | p < 0.022 |
↓P3 | 345–439 | Oz, O1, O2, Pz, P3 | p < 0.044 | |||
ERSP | ↓θ (4–7) | 302–390 | Oz, O1, O2, P3, P4 | p < 0.034 | ||
↓γ (42–47) | 570–679 | Oz, O1, O2, P3, P4 | p < 0.032 | |||
ITC | ↓θ-α (5–12) | 320–453 | Oz, O1, O2, Pz, P3 | p < 0.041 | ||
Central Figure 4 |
ERP | ↓P3 | 464–656 | Cz, C3 | p < 0.012 | |
ERSP | ↑α (7–13) | 252–541 | Cz, C3, C4 | p < 0.031 | ||
↓γ (42–47) | 566–593 | Cz, C4 | p < 0.032 | |||
ITC | ↓α (8–14) | 220–347 | Cz, C3, C4 | p < 0.018 | ||
Anterior | ERP | ↓N1 | 117–128 | Fz, F3, F4 | p < 0.044 | |
↑P2 | 207–260 | Fz, F3, F4 | p < 0.011 | |||
ERSP | ↓α (10–18) | 109–234 | Fz, F3, F4 | p < 0.003 | ||
↓γ (38–47) | 517–654 | Fz, F4 | p < 0.032 | |||
Nogo | Posterior | ERP | ↓P1, ↑N2 | 136–209 | Oz, O1, O2, Pz, P3 | p < 0.005 |
ERSP | ↑α (12–16) | 126–273 | Oz, O1, O2, Pz, P3, P4 | p < 0.003 | ||
↓γ (31–36) | 296–380 | Oz, O1, O2, Pz, P3, P4 | p < 0.018 | |||
ITC | ↓θ-α (5–14) | 308–414 | Oz, O1, O2, P3 | p < 0.005 | ||
↑γ (31–36) | 302–410 | Oz, O2, Pz, P3, P4 | p < 0.007 | |||
Central | ERSP | ↓θ (4–8) | 255–423 | Cz, C3 | p < 0.002 | |
↓γ (38–43) | 428–509 | Cz, C3, C4 | p < 0.048 | |||
ITC | ↓θ (4–8) | 291–369 | Cz, C3 | p < 0.016 | ||
↑γ (31–37) | 275–345 | Cz, C3, C4 | p < 0.041 | |||
Anterior Figure 5 |
ERP | ↓N1-P2 | 136–211 | F3, F4 | p < 0.049 | |
↓N3 | 279–344 | Fz, F3, F4, Fpz | p < 0.018 | |||
ERSP | ↓θ-α (4–11) | 277–396 | Fz, F3, F4 | p < 0.014 | ||
↓γ (38–45) | 316–517 | Fz, F3, F4, Fpz | p < 0.022 | |||
ITC | ↓θ-α (5–11) | 256–390 | Fz, F3 | p < 0.016 | ||
↑γ (34–44) | 382–511 | Fz, F3, F4 | p < 0.003 |
Note: Arrows indicated increase or decrease of ERP amplitude or ERSP/ITC in children with ADHD compared to TDC. 1 p-values below are corrected for multiples comparisons (False Discovery Rate method). ERP: Evoked-Related Potentials; ERSP: Evoked-Related Spectral Perturbation; ITC: Inter-trials Coherence.